Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg

Saved in:
Bibliographic Details
Published in:Ophthalmology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1869572615147880448
collection WordPress RSS
FRELIP Feed Integration
container_title Ophthalmology and Therapy
description
discipline_display Ophthalmology and Optometry
discipline_facet Ophthalmology and Optometry
format Online Article
RSS Article
genre Journal Article
id rss_article:98232
institution FRELIP
journal_source_facet Ophthalmology and Therapy
last_indexed 2026-07-02T03:36:25.678Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
Ophthalmology and Optometry
General
Ophthalmology and Optometry
sub_discipline_display General
sub_discipline_facet General
subject_display Ophthalmology and Optometry
General
Ophthalmology and Optometry
subject_facet Ophthalmology and Optometry
General
Ophthalmology and Optometry
title Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
title_alt Avances en el manejo de la vasculopatía coroidea polipoidea (PCV): Evidencia emergente para faricimab y aflibercept 8 mg
Avancées dans la prise en charge de la vasculopathie choroïdienne polypoïdale (PCV) : données émergentes pour le faricimab et l'aflibercept 8 mg
Avanços no manejo da vasculopatia coroidal polipoidal (PCV): Evidências emergentes para Faricimabe e Aflibercepte 8 mg
title_auth Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
title_es_txt Avances en el manejo de la vasculopatía coroidea polipoidea (PCV): Evidencia emergente para faricimab y aflibercept 8 mg
title_fr_txt Avancées dans la prise en charge de la vasculopathie choroïdienne polypoïdale (PCV) : données émergentes pour le faricimab et l'aflibercept 8 mg
title_full Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
title_fullStr Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
title_full_unstemmed Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
title_pt_txt Avanços no manejo da vasculopatia coroidal polipoidal (PCV): Evidências emergentes para Faricimabe e Aflibercepte 8 mg
title_short Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
title_sort advances in polypoidal choroidal vasculopathy (pcv) management: emerging evidence for faricimab and aflibercept 8 mg
topic Ophthalmology and Optometry
General
Ophthalmology and Optometry
url https://link.springer.com/article/10.1007/s40123-026-01405-1